Elevated levels of autoantibodies, such as antinuclear antigen (ANA) antibodies, anti-60-kDa and anti-52kDa SSA/Ro antibodies and antiphospholipid antibodies (aPLs), have been evidenced, especially in patients who have experienced severe forms of COVID-19 [115,157]. Here, CALR is linked to COVID-19.